Genus plc Stock

Equities

GNS

GB0002074580

Biotechnology & Medical Research

Market Closed - London S.E. 11:35:02 2024-05-08 am EDT 5-day change 1st Jan Change
1,880 GBX -0.32% Intraday chart for Genus plc +8.29% -13.36%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2024 * 674M 842M Sales 2025 * 711M 888M Capitalization 1.24B 1.54B
Net income 2024 * 29M 36.19M Net income 2025 * 47M 58.66M EV / Sales 2024 * 2.18 x
Net Debt 2024 * 232M 290M Net Debt 2025 * 209M 260M EV / Sales 2025 * 2.03 x
P/E ratio 2024 *
45.1 x
P/E ratio 2025 *
27.7 x
Employees 3,500
Yield 2024 *
1.71%
Yield 2025 *
1.83%
Free-Float 99.31%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.11%
1 week+7.72%
Current month+3.66%
1 month+7.47%
3 months-14.46%
6 months-13.02%
Current year-13.82%
More quotes
1 week
1 724.00
Extreme 1724
1 918.00
1 month
1 644.04
Extreme 1644.04
1 918.00
Current year
1 478.00
Extreme 1478
2 378.00
1 year
1 478.00
Extreme 1478
2 787.32
3 years
1 478.00
Extreme 1478
6 310.00
5 years
1 478.00
Extreme 1478
6 310.00
10 years
1 001.00
Extreme 1001
6 310.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 23-05-01
Director of Finance/CFO - 20-01-12
Chief Operating Officer - 10-12-31
Members of the board TitleAgeSince
Director/Board Member 71 18-05-31
Chairman 67 20-06-30
Director of Finance/CFO - 20-01-12
More insiders
Date Price Change Volume
24-05-08 1,880 -0.32% 36 997
24-05-07 1,886 +0.96% 52,865
24-05-03 1,868 +4.71% 80,575
24-05-02 1,784 +2.76% 95,900
24-05-01 1,736 -3.77% 65,694

Delayed Quote London S.E., May 08, 2024 at 08:48 am EDT

More quotes
Genus plc is a United Kingdom-based animal protein genetics company. The Company supplies breeding animals with desirable characteristics for farmers, enabling them to produce quality meat and milk. Its segments include Genus PIC, Genus ABS and Genus Research and Development. The Genus PIC segment is engaged in the porcine sales business. The Genus ABS segment is engaged in the bovine sales business. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers, so they can breed commercial pigs with desirable characteristics for pork production. It also provides technical services and advice to farmers, to maximize the performance of its breeding animals in their farms. The Company has supply chain and distribution networks in over 80 countries.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
18.86 GBP
Average target price
27.78 GBP
Spread / Average Target
+47.30%
Consensus

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW